the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese

Market Research Report

Parallel Trade in Pharmaceuticals: Past and future scenarios

Published by Urch Publishing, Ltd. Contact us : +1-860-674-8796
Published 2003/09 Content info  
Product code UR15844
Price From  US $ 1700 Order/Price list
US $ 1700 Hard Copy
US $ 1800 PDF by E-mail (Single User License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Summary

Parallel trade or parallel importation is the cross-border trade in a particular product, through a route that the manufacturer may not have originally intended. As many manufacturers operate a system whereby they sell their products at different prices in different markets, there is an incentive for those wishing to reduce the costs of their purchases to seek these products from the lower-priced markets. As the demand for cheaper products has grown, parallel trade businesses have flourished. By sourcing products from lower-priced markets to sell to consumers in higher-priced markets, these companies can offer significant savings to consumers, who thereby have an alternative to the price that the product is being sold at in their country by the original manufacturer.

This, 60,000 word strategic management, publication provides the valuable market overview and data that all pharmaceutical companies will find essential in their business.

Understand the development in this fast-moving sector:

  • Examines the impact of forthcoming EU enlargement as a new source of cheaper product
  • Describes how high drug prices in the United States is opening up the potential for imports from Canada and Mexico
  • Asks whether parallel trade will become a global issue as countries like Kenya and the Philippines experiment
  • Discusses whether parallel imports are influencing big pharma’s R&D spend
  • Latest thinking on the exhaustion of intellectual property rights in international law

Comprehensive insight into the major issues including:

  • Why price differential is not the only factor that causes parallel trade
  • Case studies and descriptions of legal battles in the EU that have been fought over the last 30 years
  • Why EU legislation and governments encourage parallel imports
  • How the AIDS crisis has become the biggest issue for governments, ethical pharmaceutical companies and parallel traders alike
  • The WTO’s role and compulsory licensing

Economic arguments for and against the existence of parallel trade in pharmaceuticals

Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.